Slingshot Biosciences, Inc. Partners With Kem-En-Tec Nordic A/S to Distribute Synthetic Cells Throughout Denmark, Sweden, Norway, Finland, and Iceland
SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Kem-En-Tec Nordic A/S, Provider of Competent Bioscience products to the Nordic laboratories since 1987.
The agreement entitles Kem-En-Tec Nordic A/S to the right to distribute and resell Slingshot Bio’s products in Denmark, Sweden, Norway, Finland, and Iceland. Through Kem-En-Tec Nordic A/S’s network of customers, Slingshot Bio will be able to establish its presence in the Nordic market with the well-established presence and expertise of Kem-En-Tec Nordic A/S which has been selling into flow cytometry for many years.
“Kem-En-Tec Nordic A/S’s network will provide us with the market penetration needed to reach our full sales potential. Slingshot Biosciences has considered many distribution partners and we are confident that Kem-En-Tec Nordic A/S’s extensive knowledge in the field, prominent presence, and large customer base will help us leverage our position in the flow cytometry market,” said Jeffrey Kim, CEO & Founder.
Slingshot Bio’s synthetic cellular controls provide consistent, precise, and accurate control for research users in the flow cytometry space by mimicking blood properties as detected by flow cytometry. The ability to manufacture consistent controls for flow cytometry has been missing for decades and is now accurately reproducible with Slingshot Bio’s unique manufacturing platform. “Kem-En-Tec Nordic strongly believes that the innovative synthetic cell controls from Slingshot will be widely adopted by researchers using flow cytometry in all the Nordic countries,” said Henrik Tind Nielsen, CCO & Co-Owner at Kem-En-Tec Nordic.
About Slingshot Biosciences, Inc.
Founded in 2012, Slingshot Biosciences is a fast-growing life sciences company with a platform technology and paradigm-shifting mission to make synthetic cells the gold standard for all cell-based applications—including diagnostics, and adoptive cell therapy development and instrument calibration. Learn more at www.slingshotbio.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220614006014/en/
Contact information
Slingshot Biosciences, Inc.
The Synthetic Cell Company
1250 45th St. Suite 330
Emeryville, CA 94608
510-770-6806
www.slingshotbio.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Suzano announces first quarter results and Cerrado Project nears completion9.5.2024 23:30:00 CEST | Press release
Suzano, the world’s largest pulp producer, which celebrates its centenary this year, announces its financial results for the first quarter of 2024 (1Q24). The highlight of the period is the progress of the Cerrado Project, the largest ever capital investment project by the company. The new pulp mill, under construction in the municipality of Ribas do Rio Pardo, Mato Grosso do Sul state, is now 94% complete and will be operational in a few weeks. It will be the largest single-line pulp mill in the world. With a total planned investment of R$22.2 billion, of which R$19.1 billion has been deployed as of the end of April, the new mill will have annual production capacity of 2.55 million tons of pulp, used in the production of sanitary papers and sanitary pads, printing & writing papers and packaging paper, among other items. Given the combined impact of the investment in the construction of the mill and lower pulp prices in recent quarters, Suzano’s US dollar leverage ended the quarter at
Rigaku Conducts Elemental Analysis of a Sample Obtained by NASA of the Asteroid Bennu9.5.2024 16:00:00 CEST | Press release
Rigaku Corporation, a Rigaku Holdings Group company and Rigaku global solution partner in X-ray analytical equipment (head office: Akishima, Tokyo; president and representative director: Jun Kawakami; hereinafter “Rigaku”), has completed analysis of particles from 101955 Bennu, a near-Earth carbonaceous asteroid classified as a type B. The analysis was performed using ZSX Primus IV, a wavelength dispersive X-ray fluorescence spectrometer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508939191/en/ ZSX Primus IV (Photo: Business Wire) The particles from Bennu are a sample obtained by OSIRIS-Rex, a spacecraft of the United States National Aeronautics and Space Administration (NASA). This analysis constitutes the second time Rigaku has been tasked with conducting analysis related to Bennu. On the first occasion, in December 2023, Rigaku measured water and carbon content in a sample from the carbonaceous asteroid using therm
John Potthoff Joins RQM+ as CEO9.5.2024 16:00:00 CEST | Press release
RQM+, a leading global MedTech contract research organization (CRO), today announced John Potthoff, Ph.D., as its new CEO. This transition comes as former CEO, Margaret Keegan, announced she plans to move out of day-to-day operations to focus on her role as an operating partner with Linden Capital Partners. Margaret will remain on the board of RQM+. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240509890767/en/ John Potthoff (right) joins MedTech leader RQM+ as its new CEO as Margaret Keegan, former CEO, announced her decision to transition to focusing on her role as an operating partner with Linden Capital Partners and will remain on the board of RQM+. (Photo: Business Wire) John, co-founder and former CEO of Elligo Health Research®, has been on the RQM+ board since 2021. He brings extensive MedTech industry expertise to his new role as CEO of RQM+. Prior to Elligo, he was CEO of Theorem Clinical Research, which had a sign
Wasabi Technologies Delivers Flexible Hybrid Cloud Storage Solutions for Data Protection9.5.2024 15:31:00 CEST | Press release
Wasabi Technologies, the hot cloud storage company, today announced a collaboration with Dell Technologies, via the Extended Technologies Complete program to bring affordable and innovative hybrid cloud solutions for backup, data protection, and long-term retention to customers. In a time marked by the exponential growth of data, organizations worldwide face the need for efficient and cost-effective storage solutions. The Wasabi-Dell collaboration addresses this challenge by providing flexible, efficient hybrid cloud solutions enabling users to optimize their data management processes while simultaneously reducing overall costs. "Dell is a clear industry leader with a broad and deep portfolio of transformative technology,” stated David Friend, co-founder and chief executive officer at Wasabi Technologies. "This collaboration will extend the reach of Wasabi's cloud storage to a broader audience, catering to users in search of a dependable, economical solutions for safeguarding their dat
Tecnotree Collaborates with People+AI to Drive Open Cloud Compute Infrastructure and AI Standardization9.5.2024 15:30:00 CEST | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, announced its partnership with people+ai, an initiative of the non-profit EkStep Foundation, on joining the Open Cloud Compute (OCC) project. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240509411323/en/ As the market leader in TM Forum Open API Conformance, Tecnotree holds the top position with the highest number of certified APIs among all members. With 59 certified Open APIs and an additional 17 transformation APIs from Camara defined by GSMA, Tecnotree offers a comprehensive suite of 76 APIs. This extensive API portfolio enables Tecnotree to support over 250 out-of-the-box journeys across the order-to-cash and provisioning lifecycle for monetization. The partnership aims to enhance India’s compute ecosystem by creating a network of providers offering accessible and customized compute resources. The platform shares a coll